Base editing corrected a mutation that causes macular degeneration, highlighting the potential of gene therapy to treat ...

Macular degeneration, particularly age-related macular degeneration, is a leading cause of vision loss worldwide. This ...

Red light therapy may help slow down the progression of macular degeneration. But more research is needed into the long-term effects and safety of red light therapy for the eyes. Red light therapy ...

Investigators advised clinicians of the potential for dystrophies that mimic age-related macular degeneration and other ...

Avirmax Biopharma Inc. has begun IND-enabling studies of ABI-201, a gene therapy for dry age-related macular degeneration (AMD). ABI-201 is an AAV vector that delivers three genes to correct the ...

A team of scientists at the National Institutes of Health (NIH) has developed an eye drop that successfully slowed vision ...

Macular degeneration and cataracts are two different ... injections [MR GZ] Wet AMD can be treated with photodynamic therapy and anti-vascular endothelial growth factor (anti-VEGF) drugs, which ...

March 7, 2025 – The FDA has approved a new gene therapy for macular telangiectasia type 2 (MacTel), a rare eye disease that causes vision loss. The approval marks the first and only ...

Age-related Macular Degeneration is the leading cause of irreversible ... AAV.N54 is the only engineered capsid to deliver macula-targeted gene expression via intravitreal injection.

a leader in developing the next generation of AAV gene therapies ... dry AMD and many other retinal disorders." Age-related Macular Degeneration is the leading cause of irreversible blindness ...